EPISODE · Jun 9, 2026 · 43 MIN
The future of Biotech investing: from genetic disease to patient impact | Luc Dochez
from Bee Formless™ Flow Driven CEO
In this episode of the Bee Formless™ Flow Driven CEO & VC Podcast, I connected with Luc Dochez to explore life, leadership, business, investing and the future of biotech through breakthrough therapies, genetic disease, patient outcomes and the responsibility that comes with allocating capital in human health.Luc is Managing Partner at Droia Ventures, a specialist life sciences venture firm investing in oncology and genetic diseases. What I appreciated most throughout our conversation was that while we spoke about science, innovation and investing, the discussion continually returned to people.We explored precision medicine, breakthrough therapies, rare diseases, leadership, conscious capital and what it takes to move complex science from the laboratory to the patient.There was also a fascinating conversation around the transition from CEO to investor. I loved how Luc described it as moving from parent to grandparent, shifting from direct control and decision-making towards guidance, trust and stewardship.For all the discussion around biotech, investing and innovation, I found myself coming back to something close to my heart and my family’s experience navigating my dad’s complex and terminal cancer. Behind every disease, every therapy and every investment decision is a person, a family and a future that matters.Luc is one passionate and deeply dedicated person when it comes to improving patient outcomes and advancing therapies for those who need them most.The Shape Shift in MotionAt the heart of this episode was a shift from treating symptoms to understanding causes, from investing for returns alone to investing for patient outcomes, and from leading through control to leading through trust, stewardship and long-term impact.This is how that shift unfolded through the Bee Formless™ methodology:LEARN (Letting go)✨ Leadership is not always about control✨ Better outcomes begin by understanding root causes✨ Meaningful innovation requires both patience and convictionUNLEARN (Create, reimagine & reshape)✨ Reimagine healthcare through precision medicine and personalised therapies✨ Create investment models that support long-term patient impact✨ Reshape leadership from authority towards guidance and stewardshipRELEARN (Test & implement)✨ Build solutions around real human needs✨ Stay focused on long-term outcomes over short-term noise✨ Make decisions through the lens of those ultimately being servedACTIVE RECOVERY (Reflect & reset)✨ Where are you treating symptoms instead of causes?✨ What decisions would change if people came before process?✨ How might trust create better outcomes than control?Where to find more:🔗 https://www.linkedin.com/in/luc-dochez-a20b0b11🌐 https://droiaventures.com💭 What changes when we place people at the centre of our decisions rather than treating them as an outcome of them?If something is shifting for you in leadership, business, investing or growth, begin with a Strategic Shape Shift Diagnostic:https://calendly.com/beeformless/strategicshapeshiftdiagnostic#beeformless #flowdrivenvc #biotech #venturecapital #oncology #geneticdisease #precisionmedicine #consciouscapital #leadership #lifesciences #droiaventures
What this episode covers
In this episode of the Bee Formless™ Flow Driven CEO & VC Podcast, I connected with Luc Dochez to explore life, leadership, business, investing and the future of biotech through breakthrough therapies, genetic disease, patient outcomes and the responsibility that comes with allocating capital in human health.Luc is Managing Partner at Droia Ventures, a specialist life sciences venture firm investing in oncology and genetic diseases. What I appreciated most throughout our conversation was that while we spoke about science, innovation and investing, the discussion continually returned to people.We explored precision medicine, breakthrough therapies, rare diseases, leadership, conscious capital and what it takes to move complex science from the laboratory to the patient.There was also a fascinating conversation around the transition from CEO to investor. I loved how Luc described it as moving from parent to grandparent, shifting from direct control and decision-making towards guidance, trust and stewardship.For all the discussion around biotech, investing and innovation, I found myself coming back to something close to my heart and my family’s experience navigating my dad’s complex and terminal cancer. Behind every disease, every therapy and every investment decision is a person, a family and a future that matters.Luc is one passionate and deeply dedicated person when it comes to improving patient outcomes and advancing therapies for those who need them most.The Shape Shift in MotionAt the heart of this episode was a shift from treating symptoms to understanding causes, from investing for returns alone to investing for patient outcomes, and from leading through control to leading through trust, stewardship and long-term impact.This is how that shift unfolded through the Bee Formless™ methodology:LEARN (Letting go)✨ Leadership is not always about control✨ Better outcomes begin by understanding root causes✨ Meaningful innovation requires both patience and convictionUNLEARN (Create, reimagine & reshape)✨ Reimagine healthcare through precision medicine and personalised therapies✨ Create investment models that support long-term patient impact✨ Reshape leadership from authority towards guidance and stewardshipRELEARN (Test & implement)✨ Build solutions around real human needs✨ Stay focused on long-term outcomes over short-term noise✨ Make decisions through the lens of those ultimately being servedACTIVE RECOVERY (Reflect & reset)✨ Where are you treating symptoms instead of causes?✨ What decisions would change if people came before process?✨ How might trust create better outcomes than control?Where to find more:🔗 https://www.linkedin.com/in/luc-dochez-a20b0b11🌐 https://droiaventures.com💭 What changes when we place people at the centre of our decisions rather than treating them as an outcome of them?If something is shifting for you in leadership, business, investing or growth, begin with a Strategic Shape Shift Diagnostic:https://calendly.com/beeformless/strategicshapeshiftdiagnostic#beeformless #flowdrivenvc #biotech #venturecapital #oncology #geneticdisease #precisionmedicine #consciouscapital #leadership #lifesciences #droiaventures
NOW PLAYING
The future of Biotech investing: from genetic disease to patient impact | Luc Dochez
No transcript for this episode yet